Functionally graded material tube and method for use of the same in implantation
View Patent ↗A device for implantation a patient may include a tubular fiber wall that defines at least one opening and at least one lumen continuous with the one opening and adapted to allow the passage of fluid. The tubular fiber wall typically contains a porosity gradient that is adapted to permit passage of different size substances at different locations along the gradient. In one aspect, a second tubular fiber wall substantially encircling the tubular fiber wall.
1. A device for implantation in an eye of a patient, comprising:
a tubular member that permits flow of fluid therethrough and is comprised of a fiber network;
wherein the fiber network has pores sized and arranged to form at least one continuous porosity gradient, wherein the porosity gradient changes, along a radius of the tubular member, from an outer tubular surface of the tubular member to an inner tubular surface of the tubular member, the outer tubular surface being more porous than the inner tubular surface and the outer tubular surface configured to contact eye tissue and permit cell ingrowth, and
wherein a first end of the tubular member is configured to extend into an anterior chamber of the eye and a second end of the tubular member is configured to extend towards a drainage area.
2. The device for implantation in an eye of a patient of claim 1 , further comprising at least a first pressure sensor in fluid communication with the anterior chamber.
3. The device for implantation in an eye of a patient of claim 1 , further comprising at least one pump operably connected to the tubular member.
4. The device for implantation in an eye of a patient of claim 1 , wherein the drainage area is a subconjunctival space, a subscleral space, a subarachnoid space, a supraciliary space, a juxta-uveal space, a choroid, Schlemm's canal, a spiscleral vein, a trabecular meshwork, a uveo-scleral pathway, a collector channel, or a combination thereof.
5. The device for implantation in an eye of a patient of claim 1 , wherein the tubular member is substantially encircled by an adhesive.
6. The device for implantation in an eye of a patient of claim 1 , wherein the fiber network comprises at least an outer layer and an inner layer, wherein each of the outer layer and inner layer contains a different porosity gradient.
7. The device for implantation in an eye of a patient of claim 1 , wherein the device is held in place by cell ingrowth into the pores of the tubular member.
8. The device for implantation in an eye of a patient of claim 1 , wherein the device is initially held in place by a biodegradable adhesive that degrades as cells grow into and around the pores of the fiber network.
9. The device for implantation in a patient of claim 1 , wherein the tubular member comprises: a polymeric material, a biostable material, a biodegradable material, a bioresorbable material, or a combination thereof.
10. The device for implantation in a patient of claim 9 , wherein the polymeric material comprises: polyvinylidene difluoride (PVDF), polylactic acid (PLA), polyglycolic acid (PGA), polyamide, silicone, or any combination thereof.
11. The device for implantation in a patient of claim 1 , wherein the tubular member is a first tubular member and wherein the device further comprises at least a second tubular wall substantially encircling the tubular fiber wall.
12. The device for implantation in a patient of claim 11 , wherein the second tubular member contains at least one porosity gradient for permitting passage of different size substances at different locations along the porosity gradient.
13. The device for implantation in a patient of claim 12 , wherein the first tubular member and the second tubular member comprise the same polymeric material.
14. The device for implantation in a patient of claim 11 , wherein the second tubular member comprises an adhesive.
15. The device of claim 1 , wherein the porosity gradient changes along direction perpendicular to a center line of the tubular member.
16. A method of treating an ocular condition, comprising:
providing a tubular shunt having a fiber wall with an inner surface forming a lumen and with an outer surface, the fiber wall having at least one continuous porosity gradient wherein the porosity of the shunt decreases, along a radius of the tubular shunt, from the outer surface of the shunt toward the inner surface of the shunt in a manner permitting cell-ingrowth into the outer surface;
inserting a first end of the tubular shunt into an anterior chamber of an eye;
locating the second end of the tubular shunt at a drainage site outside of the anterior chamber; and
permitting fluid flow from the anterior chamber to the drainage site.
17. The method of claim 16 , further comprising delivering a drug into the anterior chamber from the tubular shunt for treatment of glaucoma.
18. The method of claim 17 , wherein the permitting fluid flow from the anterior chamber to the drainage site and delivering a drug into the anterior chamber for the treatment of glaucoma occurs substantially simultaneously.
19. The method of claim 16 , further comprising monitoring location of the tubular shunt over time.
20. The method of claim 16 , further comprising monitoring fluid pressure in the anterior chamber over time.